X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

WIPO and the Research-Based Pharmaceutical Industry Team up to Facilitate Access to Key Medicine Patent Information

Yuvraj_pawp by Yuvraj_pawp
3rd October 2017
in Facilities & Operation

The World Intellectual Property Organization (WIPO) and the research-based pharmaceutical industry today launched a new partnership to promote the accessibility of patent information for health agencies tasked with procurement of medicines.

WIPO Director General Francis Gurry and Thomas Cueni, Director General of the International
Federation of Pharmaceutical Manufacturers and Associations (IFPMA), signed an agreement
establishing the Patent Information Initiative for Medicines, or “Pat-INFORMED,” on the sidelines of the
Assemblies of the Member States of WIPO.

WIPO and IFPMA, the global trade association representing the research-based pharmaceutical industry, are co-sponsors of the initiative, which originated in the industry’s efforts to add clarity to the patent information around medicines. It couples the industry’s work in this area with WIPO’s well-established expertise in organizing patent data from across the globe.

Pat-INFORMED will clearly link public patent information to registered medicines in a new online global
gateway, helping health professionals to navigate the medicine-procurement process for the benefit of
their citizens.

“Pat-INFORMED will make it easier for procurement experts to assess the patent status of medicines,
underlining how a well-designed and implemented patent system incentivizes innovation while making
available and accessible key information about patented inventions,” said Mr. Gurry. “I welcome the
engagement of IFPMA and its membership in this initiative, which responds to real needs in the public
health community.”

“We can proudly say that this collaboration with WIPO shows the private sector’s initiative to propose
practical solutions to reduce the complexity around patent information. Helping ease access to patent
information for public health authorities can help them establish smarter procurement strategies, one
building block of improved global health,” said Thomas Cueni, director general IFPMA.

Pat-INFORMED will act as a global gateway to medicine patent information. It will offer new tools and
resources to determine the existence of patents relevant to products sought by procurement bodies’
disease-management strategies or other work addressing public health needs.

Twenty leading global research-based biopharmaceutical companies have already committed to make
information available via a database to be established by Pat-INFORMED, with more organizations
expected to join.

“The Pat-INFORMED initiative launched today by IFPMA and WIPO is an important step to reduce
uncertainty and improve transparency in medicines procurement. By adding the information on the
global patent status from patent-holding companies to that from national patent offices, the process for
procurement agencies and others to determine the scope of patent protection for medicines will be
markedly improved. I am delighted that the pharmaceutical industry has taken this important step,” said

Trevor Mundel, President of the Global Health Division at the Gates Foundation.
While patent information is publicly available around the world, resources that directly link granted
patents to marketed medicines are currently only available publicly in certain countries (e.g. the USA’S
‘Orange Book’) or through private third-party databases.

Pat-INFORMED aims to help close these gaps, and make the management of patent issues in
procurement less time- and resource-intensive. Pat-INFORMED also offers qualified procurement
agencies a communication channel for follow-on inquiries, through which participating companies have
agreed to provide more detailed information about granted patents on specific products.

The online initiative is expected to be operational by mid-2018 and will provide patent information for
small molecule products within oncology; hepatitis C, cardiovascular, HIV, diabetes, and respiratory
therapy areas; and any products on the WHO Essential Medicines List that are not within these therapy
areas. In a second phase, the initiative will expand to all therapeutic areas and explore the inclusion of
complex therapeutics.

About WIPO
The World Intellectual Property Organization (WIPO) is the global forum for intellectual property policy,
services, information and cooperation. A specialized agency of the United Nations, WIPO assists its 191
member states in developing a balanced international IP legal framework to meet society’s evolving
needs. It provides business services for obtaining IP rights in multiple countries and resolving disputes.

It delivers capacity-building programs to help developing countries benefit from using IP. And it provides free access to unique knowledge banks of IP information.

About IFPMA
IFPMA represents research-based pharmaceutical companies and associations across the globe. The
research-based pharmaceutical industry’s two million employees discover, develop, and deliver
medicines and vaccines that improve the lives of patients worldwide. Based in Geneva, IFPMA has
official relations with the United Nations and contributes industry expertise to help the global health
community find solutions that improve global health.

News and Media Section at WIPO
Tel: (+41 22) – 338 81 61 / 338 72 24
Fax: (+41 22) – 338 81 40

Sadia Kaenzig, IFPMA
Tel: (+41 22) – 338 32 00
Direct: (+41 22) – 338 32 49
Email: s.kaenzig@ifpma.org

 

Previous Post

Sports Nutrition Leader Iovate Health Sciences Announces Strategic Investment by Xiwang Foodstuffs to Accelerate Growth in China

Next Post

Heptares founder richard henderson receives nobel prize in chemistry 2017 for pioneering work in cryo-em for visualising biological structures

Related Posts

New Concept Allows Physical Partnering Event
Facilities & Operation

New Concept Allows Physical Partnering Event

11th September 2020
Pfizer and Flatiron Health Announce Expanded Strategic Collaboration to Unlock Power of Real-World Evidence in Oncology
Facilities & Operation

Pfizer and Flatiron Health Announce Expanded Strategic Collaboration to Unlock Power of Real-World Evidence in Oncology

27th September 2019
Catalent To Open New Clinical Supply Facility In San Diego
Drug Development

Catalent To Open New Clinical Supply Facility In San Diego

17th September 2019
IQVIA MedTech
Facilities & Operation

IQVIA Launches IQVIA MedTech Dedicated to Medical Device and Diagnostics Industry

14th May 2019
Catalent Invests $14 Million At Its Eberbach, Germany Softgel Facility
Facilities & Operation

Catalent Invests $14 Million At Its Eberbach, Germany Softgel Facility

24th April 2019
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Innovative Medicines for Cardiovascular Disease
Facilities & Operation

Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Innovative Medicines for Cardiovascular Disease

1st March 2019
Next Post

Heptares founder richard henderson receives nobel prize in chemistry 2017 for pioneering work in cryo-em for visualising biological structures

Latest News

FDA Experts Recommend Changing COVID Jab Formulation In Fall
Manufacturing

FDA Experts Recommend Changing COVID Jab Formulation In Fall

30th June 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
Manufacturing

Novartis To Slash 8,000 Jobs To Save $1 Billion By 2024

30th June 2022
How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace
Manufacturing

How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace

27th June 2022
Australia Creates A Novel Stem Cell Production Technique
Manufacturing

Australia Creates A Novel Stem Cell Production Technique

27th June 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
Manufacturing

Novartis Promises $250M For Tropical Illnesses, Malaria

27th June 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In